1. Baillargeon L, Landreville P, Verreault R, Beauchemin J-P, Grégoire J-P, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ. 2003;169(10):1015–20.
2. Benasi G, Guidi J, Offidani E, Balon R, Rickels K, Fava GA. Benzodiazepines as a monotherapy in depressive disorders: a systematic review. Psychother Psychosom. 2018;87(2):65–74.
3. BENZODIAZEPINES (Street Names: Benzos, Downers, Nerve Pills, Tranks) (2019) Drug & chemical evaluation section, diversion control division, drug enforcement administration. https://www.deadiversion.usdoj.gov/drug_chem_info/benzo.pdf
4. Benzodiazepines and Opioids. National Institute on Drug Abuse. https://www.drugabuse.gov/drugs-abuse/opioids/benzodiazepines-opioids
5. Brandt J, Alessi-Severini S, Singer A, Leong C. Novel measures of benzodiazepine and Z-Drug utilisation trends in a Canadian provincial adult population (2001–2016). J Popul Ther Clin Pharmacol. 2019;26(1):e22–38.